Heart Disease & HIV/AIDS: Research
- Cholesterol Levels Elevated in Toddlers Taking Anti-HIV Drugs (November 21, 2011)
NIH study first to show effect in this age group; long-term significance unknown.
From U.S. National Institutes of Health
- Coronary Artery Calcification Linked to Bone Loss (July 19, 2011)
From HIVandHepatitis.com
- Marker of Cardiovascular Disease Also Associated With Bone Problems in Patients with HIV (July 18, 2011)
From aidsmap.com
- Risk of Heart Attack, Death in HIV Patients Predicted by Heart Ultrasound (July 13, 2011)
In Medical News Today
 Abacavir Agonistes (June 24, 2011)
Paul Sax, M.D., summarizes several recent studies that still seek to definitively answer the question of whether Ziagen (abacavir) is associated with a greater risk of cardiovascular disease.
From Journal Watch
- HIV Infection Raises Heart Failure Risk -- Study (May 2, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Increases the Risk for Heart Failure in Some HIV-Positive Men (April 28, 2011)
In The AIDS Beacon
- Pushing Healthy Lifestyle Cuts Risk of Chronic Disease for Blacks: Study (April 25, 2011)
In HealthDay
- Low CD4 Count Linked to Higher Heart Attack Risk With HIV (March 2011)
To read PDF, click here.
In HIV Treatment ALERTS!, from The Center for AIDS
- Ongoing Abacavir Safety Review Finds No Increased Risk of Heart Attack (March 1, 2011)
From U.S. Food and Drug Administration
- People With HIV Have High Stroke Risk: Study (January 25, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Longer Antiretroviral Therapy Favors Return to Normal HDL-C (September 15, 2010)
From National AIDS Treatment Advocacy Project
- Even Among Long-Term HIV Nonprogressors, Some Signs of Heightened Cardiovascular Risk Exist, U.S. Study Finds (September 12, 2010)
In The 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus-Infected Patients (August 6, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Coronary CT Sees Blockage in Half of HIV Group With No Heart Disease Symptoms (July 27, 2010)
From National AIDS Treatment Advocacy Project
- Low CD4s Trump Other MI Risk Factors in 6500-Person U.S. Analysis (July 21, 2010)
From National AIDS Treatment Advocacy Project
- Protease Inhibitor-to-Isentress Switch Is Effective, Lipid Friendly (July 20, 2010)
From AIDSmeds.com
- Elevated Heart and Kidney Disease Risk Despite HIV Treatment? (May 18, 2010)
In POZ Magazine
- Inflammation and Cardiovascular Risk: Is It All It's Cracked Up to Be? (March 30, 2010)
Part of a CROI 2010 wrap-up discussion with Pablo Tebas, M.D.
From The Body PRO
- Smoking Cessation Lowers Cardiovascular Risk (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Smoking Cessation Reduces CVD Risk in HIV (March 1, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Progression of Atherosclerosis Is Linked to Inflammation in People With HIV (February 23, 2010)
From aidsmap.com
- Triglycerides Linked to Heart Attack Risk in D:A:D Study (February 22, 2010)
From aidsmap.com
- Heart Risk Factors Tied to Neurocognitive Skills in SMART Substudy (February 21, 2010)
From National AIDS Treatment Advocacy Project
- T-Cell Activation and Senescence Linked to Carotid Lesions in HIV-Positive Women (February 21, 2010)
From National AIDS Treatment Advocacy Project
- Heart Risk Falls With Time Since Quitting Smoking in D:A:D (February 20, 2010)
From National AIDS Treatment Advocacy Project
- High Triglycerides Independently Raise MI Risk in D:A:D Study (February 20, 2010)
From National AIDS Treatment Advocacy Project
- Smoking Cessation Lowers Cardiovascular Risk in D:A:D Cohort (February 19, 2010)
From aidsmap.com
- RNA Spikes Predict Heart Disease, CD4s Predict Liver and Kidney Disease (February 18, 2010)
From National AIDS Treatment Advocacy Project
- High Risk of Heart Problems in People With Kidney Dysfunction (February 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- DAD: An Updated Analysis of Heart Attack Risk (February 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- Study Finds Heart Disease in Young HIV-Positive Men (February 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- The Lingering Debate With Abacavir and Heart Disease (February 2010)
To read PDF, click here.
From Project Inform
- Increased Presence, Severity of Coronary Artery Plaques in HIV-Infected Men (January 27, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Update on Inflammation and Cardiovascular Risk in People With HIV (November 2009)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- French Study Unexpectedly Uncovers Role of Substance Use in Heart Attacks (November 2009)
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- Serious Non-AIDS Health Problems (Especially Heart Problems) Appear Less Likely With Truvada Than Epzicom, But Low Bone Mineral Density Is More Likely, Switch Study Finds (October 20, 2009)
In Clinical Infectious Diseases
- Crestor May Top Pravachol as Lipid Buster Among HIVers on Norvir-Boosted Protease Inhibitors (October 15, 2009)
In AIDS
- Why Is Ziagen Associated With Heart Attacks in Some People? New Study Offers Possible Explanation (September 30, 2009)
From aidsmap.com
- Untreated HIV Associated With Less-"Elastic" Arteries, Raising Heart Disease Risk, Study Finds (September 3, 2009)
From The Body
- Long-Term HIV Treatment May Reduce Risk for Coronary Atherosclerosis, Pitt Study Finds (August 4, 2009)
From University of Pittsburgh
- Nevirapine Sports Better Lipid Profile Than Atazanavir, Study Suggests (July 20, 2009)
Patients taking nevirapine may have a lower risk of developing cardiovascular disease than those taking ritonavir-boosted atazanavir, according to a 569-patient study by European researchers. The study found that although nevirapine's efficacy was non-inferior to that of atazanavir, nevirapine appeared to have a more favorable lipid profile.
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIV, HAART, and the Heart (July 14, 2009)
From amfAR, The Foundation for AIDS Research
- Study Dismisses Protein's Role in Heart Disease (June 30, 2009)
In The New York Times
- Inflammation Test May Predict Heart Attack Risk for People With HIV (June 17, 2009)
From aidsmap.com
- HIV Itself Linked to Possible Heart Risk, Even Among Nonprogressors, Study Finds (June 3, 2009)
From The Body
- Whither Recombinant Human Leptin Treatment for HIV-Associated Lipoatrophy and the Metabolic Syndrome? (April 2009)
Christos Mantzoros, M.D., an associate professor at Harvard Medical School, offers his take on whether there's a future for leptin replacement as a treatment for metabolic complications in people with HIV. (Editorial originally published in the Journal of Clinical Endocrinology & Metabolism.)
From National AIDS Treatment Advocacy Project
- Leptin Injections May Help HIVers With Lipoatrophy, Other Metabolic Problems, According to Small Study (April 2009)
The full text of a study published in the Journal of Clinical Endocrinology & Metabolism.
From National AIDS Treatment Advocacy Project
- Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction (April 21, 2009)
In Journal of Acquired Immune Deficiency Syndromes
- Starting HIV Therapy May Improve Some Markers of Heart Health, Small Study Finds (April 21, 2009)
These new findings won't necessarily clear up the still-obscure relationship between HIV, HIV meds and heart disease, but they do support the idea that starting HIV treatment may not automatically jack up your cardiovascular risk.
From aidsmap.com
- HIV Type 1 Infection, and Not Short-Term HAART, Induces Endothelial Dysfunction (April 13, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- High Lipids May Be Harder to Treat for HIV-Positive People, Study Says (March 16, 2009)
Excerpt of the study, "Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection," published in the Annals of Internal Medicine on March 3, 2009.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- CROI 2009 Highlights: A Review of Cardiovascular Disease and HIV (March 15, 2009)
An interview with David Wohl, M.D.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Cardiovascular Risk (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected with Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). (February 13, 2009)
In Circulation
- Untreated HIV Infection Is Associated With Impaired Arterial Elasticity (February 11, 2009)
An interview with Jason Baker, M.D.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- High Prevalence of Obesity, Dyslipidemia and Inflammation Seen in Behaviorally Infected Adolescent Women (February 11, 2009)
An interview with Kathleen Mulligan, Ph.D.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV on Par With Smoking, Diabetes as Risk Factor for Atherosclerosis, Large Study Finds (February 11, 2009)
Carl Grunfeld, M.D., Ph.D., and Colette Smith present new findings from a pair of massive studies that explore factors associated with cardiovascular risk in HIV-infected patients. Dr. Grunfeld's data suggest that HIV itself is a major risk factor for atherosclerosis -- a far greater risk, in fact, than any that may be posed by the use of antiretrovirals.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Jens Lundgren, M.D., Discusses New Findings Regarding MI Risk of Specific Antiretrovirals (February 9, 2009)
The latest data from D:A:D indicate that lopinavir/ritonavir does increase myocardial infarction risk, but efavirenz, nevirapine and tenofovir do not. In this interview, Jens Lundgren, M.D., and HIV advocate Jeff Berry take part in a fascinating discussion on the new findings and their possible underlying causes.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Ptients: the Role of HIV, Antiretroviral Therapy, and Lipodystrophy (February 1, 2009)
In Journal of Acquired Immune Deficiency Syndromes
- Illnesses Associated With Aging May Strike HIVers Earlier, Study Suggests (January 26, 2009)
From National AIDS Treatment Advocacy Project
- Abacavir Treatment Doesn't Cause Changes in Biomarkers Linked to Heart Attack, Suggests Small Study (December 2, 2008)
From aidsmap.com
- Surprising Rate of Serious Heart Condition Found in Those on HAART (December 2008)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Australia: AIDS Drugs Trigger Inflammation Linked to Diabetes, Study Says (November 18, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Markers of Inflammation and Blood-Clotting Tied to Hazards of Intermittent HIV Treatment (October 21, 2008)
From U.S. National Institutes of Health
- Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients (September 1, 2008)
In The American Journal of Cardiology
- Low CD4 Cell Count, But Not HIV Treatment, Increases Risk of Hardening of the Arteries (August 19, 2008)
From aidsmap.com
- Screening and Assessment of Coronary Heart Disease in HIV-Infected Patients (July 8, 2008)
In Circulation, from American Heart Association
- Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients (June 19, 2008)
In Circulation, from American Heart Association
- Insulin Resistance May Predict Risk of Cardiovascular Disease in HIV (May 8, 2008)
From aidsmap.com
- Conventional Cardiovascular Risk Factors in HIV Infection: How Conventional Are They? (May 2008)
In Current Opinion in HIV and AIDS
- Heart Attack Rates Not Rising Among HIV-Positive People, Study Finds (April 23, 2008)
From Medscape
- Protease Inhibitors Increase Fibrinogen Levels: Increased Risk for Hardening of the Arteries (April 8, 2008)
- Anti-Inflammatory Drug Could Reduce Heart Disease Risk in Patients With HIV (March 14, 2008)
From aidsmap.com
- Abacavir, Didanosine Associated With Higher Heart Attack Risk, D:A:D Study Finds (February 5, 2008)
An interview with Jens Lundgren, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Study Finds Heart Trouble With Ziagen and Videx (February 4, 2008)
From Project Inform
- Short-Term Ritonavir Exposure Impacts HDL, CD36 and Triglyceride Levels in Healthy Volunteers (February 4, 2008)
Marta Boffito, M.D., Ph.D., discusses her study, which examines the possible role of ritonavir in increasing cardiovascular risk.
From The Body PRO
- Position Statement by the D:A:D Steering Committee (February 4, 2008)
A discussion of the significance of a study examining the association between use of abacavir, didanosine and lamivudine and the risk of myocardial infarction.
To read PDF, click here.
From D:A:D Steering Committee
- Increased Risk of Myocardial Infarction Associated With Abacavir and ddI (February 4, 2008)
From HIV i-Base
- HIV-Positive Patients Have High Prevalence of Asymptomatic Heart Disease in US Study, But Traditional Risk Factors and Cocaine Use Main Causes (January 23, 2008)
From aidsmap.com
- Spanish Find Low Prevalence of Peripheral Arterial Disease in HIV-Positive Patients With Heart Disease Risks (January 9, 2008)
From aidsmap.com
- Ten-year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women (October 15, 2007)
In Clinical Infectious Diseases
- Anti-HIV Treatment, Weight and Low Income Risk Factors for Heart Disease (October 1, 2007)
From aidsmap.com
- Hardening of the Arteries Found in One in Five Patients in Swiss HIV Cohort (September 17, 2007)
From aidsmap.com
- IAS: Cardiovascular Disease and Diabetes Increasing as Causes of Death for People With HIV in Brazil (July 25, 2007)
From aidsmap.com
- Insight Into the Burden of Coronary Artery Disease in HIV-Infected Patients (July 24, 2007)
This is the first moderately sized study to examine at a histological level the lesions associated with the increased risk of myocardial infarction among HIV-infected individuals that has been reported in multiple case series and cohort studies. Margaret Hoffman-Terry, M.D., reports.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
- Cardiovascular Risk Assessment, Treatment Vital for HIV Patients on Therapy (June 20, 2007)
From American Heart Association
- High LDL Cholesterol Levels May Drop by Switching Sustiva to Viramune, Study Says (June 12, 2007)
From AIDSmeds.com
- Antiretroviral Therapy Carries Same Risk of Ischaemic Heart Disease as 1-4 Cigarettes a Day, Danish Study Shows (May 23, 2007)
From aidsmap.com
- Popular Diabetes Drug May Increase Heart Attack Risk, FDA Warns (May 22, 2007)
The widely used diabetes drug Avandia (rosiglitazone) may increase a person's risk for heart proboems, according to a new warning issued by the U.S. Food and Drug Administration (FDA).
In The New York Times
- Heart Attack Risk Seen in Drug for Diabetes (May 22, 2007)
In The New York Times
- No Imminent Epidemic of Heart Disease Among HIVers on Meds, Expert Says (May 1, 2007)
From aidsmap.com
- HIV Infection Doubles Risk of Heart Attack in US Patients; Risk Trebled in Women (April 27, 2007)
From aidsmap.com
- HIVers -- Particularly Women -- More Likely to Have Heart Attacks, New Study Finds (April 24, 2007)
In Washington Post
- Metabolic Complications: A CROI Round-Up (February 28, 2007)
Includes an analysis of research examining lopinavir/ritonavir vs. efavirenz, the use of growth hormone releasing factor to treat fat gain, the link between cardiovascular disease and HIV treatment, the use of ezetimibe (a choleserol-reducing agent) and the latest on bone health in HIV-infected patients.
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Is HIV Causing Cardiovascular Disease by its Own Effects on Cholesterol? (December 18, 2006)
From aidsmap.com
- Deep Vein Thrombosis Risk Increases as HIV Disease Worsens (August 7, 2006)
- Will HIV Meds Raise Your Cholesterol? Depends on Your Race, Study Suggests (March 2006)
In PLoS Medicine
- Cardiovascular Risk and Antiretroviral Therapy: New Research on Epidemiology, Pathogenesis and Treatment (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
- HIV JournalView: A Supersized Epidemic: The Twin Problems of Obesity and HIV (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- HIV JournalView: Dosing Adjustment Likely Needed for Statins Taken With NNRTIs (January 2006)
[Archived Article]
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- HIV JournalView: Obesity Growing Increasingly Common Among HIV-Infected Patients (September 2005)
[Archived Article]
A new report cautions that the major body shape issue confronting HIV-infected U.S. patients -- particularly African Americans -- is garden-variety obesity.
From The Body PRO
- HIV JournalView: HAART Associated With Long-Term Risk of Systolic Hypertension (July/August 2005)
[Archived Article]
From The Body PRO
- HIV JournalView: Carotid Intima-Media Thickness Not Associated With Protease Inhibitor Use (July/August 2005)
[Archived Article]
From The Body PRO
- Efavirenz Reduces Plasma Levels of Popular Statins (July/August 2005)
[Archived Article]
From The Body PRO
- HIV JournalView: Managing Dyslipidemias: Is It Better to Fight or Switch? (July/August 2005)
[Archived Article]
From The Body PRO
- HIV JournalView: Changes in Atherosclerosis Progression in HIV: Evolution of Carotid Intima-Media Thickness (May/June 2005)
[Archived Article]
From The Body PRO
- Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults (January 6, 2005)
[Archived Article]
In New England Journal of Medicine
- Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs (October 26, 2004)
[Archived Article]
A study finds an increased risk of sudden death from cardiac causes.
In AIDS Treatment News, from AIDS Treatment News
- Extended-Release Niacin May Reduce Dyslipidemia, But Dangerous for Diabetic Patients (October 2004)
[Archived Article]
Quick recap of a study in the journal Clinical Infectious Diseases.
In HIV Treatment ALERTS!, from The Center for AIDS
- Breathing Problems: Pulmonary Arterial Hypertension More Common, Treatment More Complicated in HIV-Positive People (October 2004)
[Archived Article]
In HIV Treatment ALERTS!, from The Center for AIDS
- HAART Users Warned About Combination of Two Lipid-Lowering Drugs (September 17, 2004)
[Archived Article]
When fibrates and glitazones are prescribed together in people on HAART, they appear to significantly raise triglycerides and dramatically lower good cholesterol.
From Canadian AIDS Treatment Information Exchange
- Stroke Risk, Odds of Bypass Surgery Increase for Every Year on HAART (August 27, 2004)
[Archived Article]
New results from the landmark D:A:D study supplement last year's findings that heart attack risk increases 26% for each year on HAART.
From aidsmap.com
- Protease Inhibitors Appear More Likely to Cause Atherosclerosis Than NNRTIs (July 15, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- HDL Benefit Is Maintained With Extension of Nevirapine and Efavirenz Treatment in 2NN Study (July 14, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- Increased Cardiovascular Risk Indices in HIV-Infected Women (July 14, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- Hypertriglyceridemic Patients on HAART Have Increased Risk of Cardiovascular Disease (July 14, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- HIV and Cardiovascular Disease: Responding to the Risk (April 2004)
[Archived Article]
An in-depth review of research on the increasingly complicated topic of cardiovascular disease in people with HIV.
In The PRN Notebook
- Atherosclerosis Risk Increased With HIV; Treatment Effects Unclear (March 26, 2004)
[Archived Article]
A major study finds that HIV infection itself is associated with increased risk of heart disease.
In AIDS Treatment News, from AIDS Treatment News
- HIV "Raises Heart Disease Risk" (March 16, 2004)
[Archived Article]
Researchers find higher rates of atherosclerosis among people with HIV, particularly those who smoke or have high blood pressure.
From BBC News
- Diabetes Drug and Exercise Help Reduce Heart Disease Risk and Improve Body Shape in HAART Patients (March 12, 2004)
[Archived Article]
From aidsmap.com
- Cardiovascular Disease Risk Factors and Antiretroviral Therapy in an HIV-Positive UK Population (March 2004)
[Archived Article]
In HIV Medicine
- Efavirenz May Reduce Blood Levels of Cholesterol Drugs (March/April 2004)
[Archived Article]
A study presented at CROI 2004 suggests an interaction between efavirenz and simvastatin (Zocor) or atorvastatin (Lipitor).
In Positively Aware, from Test Positive Aware Network
- A Review of the Cardiovascular Complications of HIV/HAART (February 11, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Color Doppler Ultrasonographic Comparison of PI vs. NNRTI Regimens (February 10, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV-Infected Patients Have Multiple Risk Factors for Cardiovascular Disease (February 9, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV May Trigger Events That Lead to Severe Heart Attack (January 2004)
[Archived Article]
In American Heart Journal
- Elevated Blood Pressure in HIV-Infected Individuals Receiving Highly Active Antiretroviral Therapy (November/December 2003)
[Archived Article]
In HIV Clinical Trials
- Endothelial Function in HIV-Infected Patients Receiving Protease Inhibitor Therapy: Does Immune Competence Affect Cardiovascular Risk? (November 2003)
[Archived Article]
Abstract of a study in the Quarterly Journal of Medicine.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Association Between Protease Inhibitor Use and Increased Cardiovascular Risk in Patients Infected With Human Immunodeficiency Virus: A Systematic Review (September 12, 2003)
[Archived Article]
In Clinical Infectious Diseases
- Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events (August 20, 2003)
[Archived Article]
Coronary heart disease almost never happens to people with no risk factors, according to this study of HIV-negative patients.
In Journal of the American Medical Association
- HIV Patients Have More Heart Disease Risk Factors (July 25, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Evidence Mounts Regarding Antiretroviral Therapy-Associated Cardiovascular Complications (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- It Is Reasonable to Modify Therapy in Patients With Multiple Cardiovascular Risk Factors (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Metabolic and Virologic Responses to Different Regimens Vary by Gender and Race (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Switch to Nevirapine From Protease Inhibitor Lowers Triglycerides and Maintains Viral Load Suppression (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Trizivir Causes Lowest Triglycerides Rise in Comparison With Combivir + Nelfinavir or d4T (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- HIV and Cardiovascular Medicine (July 2003)
[Archived Article]
In Heart
- Exercise Linked to Lower Triglyceride Levels on HAART (June 18, 2003)
[Archived Article]
Vitamin E intake is also associated with lower blood pressure and body fat percentage.
From aidsmap.com
- Highly Active Antiretroviral Therapy Does Not Significantly Raise Cholesterol Levels, Study Says (June 11, 2003)
[Archived Article]
Contrary to what many people theorized, HAART actually appears to bring cholesterol levels back to what they were before a person was infected with HIV.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Early HAART Extends Life, Costs Less, Study Says -- Despite Cardiovascular Risks (June 11, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- European Agency Backs Cardiovascular Safety Studies on HIV Drugs (May 16, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Cardiocontradictions (May 2003)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Link Between HAART, Cardiovascular Events Questioned (April 22, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Older PIs Linked to Early Coronary Artery Disease (April 7, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Prediction of Coronary Heart Disease Risk in HIV-Infected Patients With Fat Redistribution (April 1, 2003)
[Archived Article]
In Clinical Infectious Diseases
- Hearts, Flowers, HAART (April 2003)
[Archived Article]
An overview of developing antietrovirals noted at CROI 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- HAART to Heart Talk (April 2003)
[Archived Article]
Continued controversy over HAART-related vascular disease risk.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Retroviruses Conference Clinical News: Interview With Cal Cohen, M.D. (March 14, 2003)
[Archived Article]
Dr. Cohen discusses starting antiretroviral therapy (tenofovir vs. d4T, efavirenz vs. nevirapine), new protease inhibitor information (atazanavir and fos-amprenavir, a.k.a. "908") and antiretroviral-associated cardiovascular problems (the D:A:D study).
In AIDS Treatment News, from AIDS Treatment News
- Heart Disease and HAART: Conflicting Studies (Spring 2003)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Veterans Affairs, University of California-San Diego Study Finds Newer AIDS Drugs Don't Cause Cardiac Ills (February 21, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection (February 20, 2003)
[Archived Article]
In New England Journal of Medicine
- Exposure to HAART Is Associated With an Increased Risk of Myocardial Infarction: The D:A:D Study (February 13, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Carotid Intima-Media Thickness in HIV-Infected and Uninfected Adults: ACTG 5078 (February 13, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Can You Fight Heart Disease With Fish? (January 21, 2003)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Cost-Effectiveness Implications of the Timing of Antiretroviral Therapy in HIV-Infected Adults (November 25, 2002)
[Archived Article]
A study asserts that, generally speaking, the risks of lipodystrophy and heart disease are outweighed by the benefits of early HIV treatment.
In Archives of Internal Medicine
- Heart-Disease Risk and C-Reactive Protein (November 22, 2002)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Metabolic Toxicities and HIV (November/December 2002)
[Archived Article]
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Incidence of Cardiac Abnormalities in Children With HIV Infection (October 2002)
[Archived Article]
An abstract from Journal of Pediatrics.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Another Cardiovascular Risk With Protease Inhibitors? (September 2002)
[Archived Article]
In HIV Treatment ALERTS!, from The Center for AIDS
- A Prospective, Multicenter, Randomized Trial Comparing the Efficacy and Safety of Fenofibrate Versus Pravastatin in HIV-Infected Subjects With Lipid Abnormalities (ACTG 5087) (July 11, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Perspective of HIV-Associated Coronary Heart Disease (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Simplification of Protease Inhibitor-Based Highly Active Antiretroviral Regimens With Abacavir Improves Hyperlipidemia and Maintains Viral Suppression in HIV-1-Infected Adults (ESS40003) (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- 9th Retrovirus Conference Coverage: Cardiovascular Complications of Therapy (Spring 2002)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Study Says AIDS Drugs May Increase Heart Attack Risk (March 1, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Distinguishable Lipid Profiles Between PI and NNRTI Therapy May Carry Different Risk of Cardiovascular Disease (CVD) (February 25, 2002)
[Archived Article]
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Risks for Cardiovascular Disease Associated With Antiretroviral Therapy (December 18, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Pulmonary Hypertension Associated With HIV Infection (November 2001)
[Archived Article]
In Body Positive, from Body Positive
- Cardiovascular Risk Factors in HIV Patients: Association With Antiretroviral Therapy (The DAD Study) (October 30, 2001)
[Archived Article]
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Combined Antiretroviral Therapy Causes Cardiomyopathy (July 10, 2001)
[Archived Article]
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Increases in Cardiovascular Disease Risk (March 22, 2001)
[Archived Article]
Report from the 8th Conference on Retroviruses and Opportunistic Infections.
In STEP Ezine, from Seattle Treatment Education Project
- Do Protease Inhibitors Increase the Risk for Coronary Heart Disease Among HIV-Positive Patients-Follow-Up Through June 2000 (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- ACTG 5056: Metabolic Status and Cardiovascular Disease Risk for a Cohort of HIV-1-Infected Persons Durably Suppressed on an Indinavir-Containing Regimen (ACTG 372A) (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time Is Now (September 2000)
[Archived Article]
In Clinical Infectious Diseases
- Lipodystrophy and Metabolic Complications of HIV (September 2000)
[Archived Article]
In The 40th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Impact of Highly Active Antiretroviral Therapy in HIV-Positive Patients With Cardiac Involvement (May 2000)
[Archived Article]
In Journal of Infection
- Cardiac Manifestations of Acquired Immunodeficiency Syndrome (March 13, 2000)
[Archived Article]
In Archives of Internal Medicine
- Myocarditis and Cardiotropic Viral Infection Associated With Severe Left Ventricular Dysfunction in Late-Stage Infection With Human Immunodeficiency Virus (October 1994)
[Archived Article]
In Journal of the American College of Cardiology
|
Advertisement
|
Email
Glossary
